I am a physician and biomedical researcher interested in molecular and translational medicine, where particular basic research can be implemented into clinical studies. I have done my basic and postgraduate studies in the universities of Torvergata (Italy), Ilia state (Georgia), and Vienna (Austria), respectively. Following several years of laboratory and clinical experiences, I got interested in the molecular pathogenesis of metabolic diseases and, in particular, diabetes, obesity, and metabolic syndrome. Within my thesis, I studied cellular signaling involved in diabetic cells and interplay with inflammatory pathways. Later on, I focused on studying the association of microbiota to diabetes and obesity within my research work at the University of Silesia. Furthermore, I have several cooperations with different research groups with various backgrounds.
Currently, I work as a postdoc researcher in the group of Dr. Guzowski, PAN, to develop a microfluidic method to encapsulate pancreatic cells using biocompatible hydrogels. This is a funded project aiming to engineer 3D pancreatic microtissues applicable for type 1 diabetic patients as micro transplants. We work with microfluidic, a high-throughput technology with a vast area of applications. Recently I have been working to extend and optimize microfluidic applications in different aspects of organ-on-a-chip and 3D cell culture. Likewise, encapsulation of regulatory lymphocytes for the purpose of cell therapy in autoimmune disorders and cancer cells to compose a 3D model for drug resistance studies. Our institute is highly interdisciplinary, with lots of research potential that can be translated into medical applications.